FDA Drafts Guidance on Replacing Reagents for IVD Devices Post author:Sam Post published:February 15, 2018 Post category:The GMP Letter The FDA issued draft guidance to provide updates on in vitro diagnostics’ replacement reagents. Source: The GMP Letter You Might Also Like Taiwan Includes Quality Requirements in New Medical Device Law February 7, 2020 FDA Cautions Bayer Over Postmarket Requirements for Essure August 3, 2018 UK Offers Grace Period for Sudden Notified Body Withdrawals February 7, 2020